Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-09 Sale | 2023-06-09 7:00 pm | Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer | 12,500 | $128.61 | $1,607,635 | 37,600 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-09 Exercise | 2023-06-09 7:00 pm | N/A N/A | Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer | 12,500 | $63.55 | 37,600 (Direct) | View |
| 2023-06-09 Exercise | 2023-06-09 7:00 pm | N/A 2032-02-27 | Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer | 12,500 | $0 | 37,600 (Direct) | View |
| 2023-02-28 Option Award | 2023-02-28 6:45 pm | N/A 2033-02-28 | Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer | 30,000 | $0 | 30,100 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-01 9:22 pm | N/A 2032-02-28 | Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer | 50,000 | $0 | 50,100 (Direct) | View |
| 2021-05-31 Option Award | 2021-06-02 7:19 pm | N/A 2031-05-31 | Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer | 205,000 | $0 | 205,100 (Direct) | View |
Ownership | 2021-05-11 7:31 pm | N/A N/A | Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer | 0 | $0 | 100 (Direct) | View |